Genesco Inc.
DB:GN8 Rapport sur les actions
Capitalisation boursière : €324.3m
Genesco Bilan de santé
Santé financière contrôle des critères 4/6 Genesco possède un total de capitaux propres de $532.6M et une dette totale de $77.8M, ce qui porte son ratio d'endettement à 14.6%. Son actif total et son passif total sont $1.4B et de $851.1M. L'EBIT de Genesco est $7.9M ce qui fait que son ratio de couverture des intérêts 1.3. Elle dispose de liquidités et de placements à court terme de $45.9M.
Informations clés Ratio de couverture des intérêts 1.3x Argent liquide US$45.86m Fonds propres US$532.62m Total du passif US$851.13m Total des actifs US$1.38b
Mises à jour récentes de la santé financière
Afficher toutes les mises à jour Genesco Inc. Appoints Cassandra Harris as Senior Vice President, Finance, Effective October 7, 2024
Second quarter 2025 earnings released: US$0.91 loss per share (vs US$2.79 loss in 2Q 2024) Sep 06
Genesco Inc. to Report Q2, 2025 Results on Sep 06, 2024 Aug 26
Journeys Announces the Appointment of Stacy Doren as Executive Vice President and Chief Marketing Officer, Effective August 1, 2024 Jul 23
First quarter 2025 earnings released: US$2.22 loss per share (vs US$1.60 loss in 1Q 2024) Jun 04
Genesco Inc. Reaffirms Earnings Guidance for the Year 2025 May 31
Genesco Inc., Annual General Meeting, Jun 27, 2024 May 21
Genesco Inc. to Report Q1, 2025 Results on May 31, 2024 May 18
Full year 2024 earnings released: US$2.10 loss per share (vs US$5.80 profit in FY 2023) Mar 10
Genesco Inc. Provides Revenue Guidance for Fiscal 2025 Mar 08
Now 20% overvalued Mar 02
Genesco Inc. to Report Q4, 2024 Results on Mar 08, 2024 Feb 27
Now 20% overvalued Feb 13
Now 20% undervalued after recent price drop Jan 11
Genesco Names Chris Santaella as Executive Vice President and Chief Merchandising Officer of Journeys Group, Effective February 5, 2024 Jan 05
Now 21% undervalued after recent price drop Dec 07
Third quarter 2024 earnings released: EPS: US$0.60 (vs US$1.68 in 3Q 2023) Dec 03
Genesco Inc. Revises Earnings Guidance for the Fiscal Year 2024 Dec 01
Investor sentiment improves as stock rises 18% Dec 01
Now 21% undervalued Nov 19
Genesco Inc. to Report Q3, 2024 Results on Dec 01, 2023 Nov 17
Now 21% undervalued Oct 10 Genesco Inc. Revises Revenue Guidance for the Fiscal Year 2024
Second quarter 2024 earnings released: US$2.79 loss per share (vs US$0.60 profit in 2Q 2023) Sep 01
Genesco Inc. to Report Q2, 2024 Results on Aug 31, 2023 Aug 18
Independent Director recently bought €236k worth of stock Jun 16
New major risk - Earnings quality Jun 09
Chairman recently bought €176k worth of stock Jun 01
First quarter 2024 earnings released: US$1.60 loss per share (vs US$0.38 profit in 1Q 2023) May 26
Genesco Inc. Revises Revenue Guidance for the Fiscal Year 2024 May 26
Genesco Inc. to Report Q1, 2024 Results on May 25, 2023 May 16
Genesco Inc., Annual General Meeting, Jun 22, 2023 May 13
Investor sentiment deteriorates as stock falls 24% Mar 16
Full year 2023 earnings released: EPS: US$5.80 (vs US$8.11 in FY 2022) Mar 10
High number of new directors Feb 02
Third quarter 2023 earnings released: EPS: US$1.68 (vs US$2.30 in 3Q 2022) Dec 03
Genesco Inc. Revises Earnings Guidance for the Year 2023 Dec 03
Genesco Inc. Announces Board Changes Nov 23
Genesco Inc. to Report Q3, 2023 Results on Dec 02, 2022 Nov 18
Investor sentiment deteriorated over the past week Sep 08
Genesco Inc. Revises Earnings Guidance for the Year 2023 Sep 03
Second quarter 2023 earnings released: EPS: US$0.60 (vs US$0.76 in 2Q 2022) Sep 02
Genesco Inc. Revises Earnings Guidance for the Year 2023 Sep 02
Genesco Inc. to Report Q2, 2023 Results on Sep 01, 2022 Aug 18
Investor sentiment improved over the past week Jul 20
Genesco Appoints Gregory A. Sandfort as Lead Independent Director Jun 28
First quarter 2023 earnings released: EPS: US$0.38 (vs US$0.62 in 1Q 2022) May 27
Genesco Inc. Provides Sales Guidance for the Full Fiscal Year 2023 May 27
Genesco Inc., Annual General Meeting, Jun 23, 2022 May 14
Genesco Inc. to Report Q1, 2023 Results on May 26, 2022 May 13
High number of new directors Apr 27
Full year 2022 earnings: Revenues and EPS in line with analyst expectations Mar 11
Genesco Inc. to Report Q4, 2022 Results on Mar 10, 2022 Feb 25
Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Dec 05
Genesco Inc. Provides Earnings Guidance for the Fiscal 2022 Dec 05
Investor sentiment improved over the past week Nov 06
Senior VP recently sold €100k worth of stock Sep 25
Senior VP of Finance & Interim CFO recently bought €85k worth of stock Sep 09
Second quarter 2022 earnings released: EPS US$0.76 (vs US$1.34 loss in 2Q 2021) Sep 03
High number of new directors Aug 27
Legion Partners Reinforces the Need for Additional Board Change at Genesco Jul 03
Legion Partners Four Director Candidates Issue Letter to Genesco Shareholders Jul 01
Legion Partners Responds to Genesco Jun 30
Legion Partners Issues Statement to Genesco Jun 25
Legion Partners Releases Presentation Outlining the Case for Boardroom Change at Genesco Jun 23
Legion Partners Issues Letter to Shareholders of Genesco Jun 15
Genesco Inc. Not to Provide Guidance for 2022 May 28
Genesco Inc. Not Provides Guidance for the Fiscal Year 2022 Mar 12
Full year 2021 earnings released: US$3.94 loss per share (vs US$3.97 profit in FY 2020) Mar 12
Revenue beats expectations Mar 12
New 90-day high: €39.80 Mar 05
Genesco Inc. to Report Q4, 2021 Results on Mar 11, 2021 Feb 26
Genesco Inc. Do Not Provide Guidance for the Fiscal Year 2021 Dec 06
Third quarter 2021 earnings released: EPS US$0.52 Dec 05
Revenue beats expectations Dec 05 Genesco Inc. Announces Executive Changes
Genesco Inc. to Report Q3, 2021 Results on Dec 04, 2020 Nov 20 Genesco Inc. Announces CFO Changes
Genesco Inc. Appoints John F. Lambros to Board of Directors Oct 29
Genesco Inc. Does Not Provide Earnings Guidance for the Fiscal Year 2021 Sep 04
Genesco Inc. to Report Q2, 2021 Results on Sep 03, 2020 Aug 21 Genesco Inc.(NYSE:GCO) dropped from S&P Retail Select Industry Index Jun 22
Analyse de la situation financière
Passif à court terme: Les actifs à court terme de GN8 ( $606.7M ) dépassent ses passifs à court terme ( $395.7M ).
Passif à long terme: Les actifs à court terme de GN8 ( $606.7M ) dépassent ses passifs à long terme ( $455.5M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de GN8 ( 6% ) est considéré comme satisfaisant .
Réduire la dette: Le ratio d'endettement de GN8 est passé de 12.9% à 14.6% au cours des 5 dernières années.
Couverture de la dette: La dette de GN8 est bien couverte par le flux de trésorerie opérationnel ( 146.3% ).
Couverture des intérêts: Les paiements d'intérêts de GN8 sur sa dette ne sont pas bien couverts par l' EBIT ( 1.3 x couverture).
Découvrir des entreprises saines Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}